Analysis of the clinical antibacterial and antituberculosis pipeline

by Theuretzbacher U, Gottwalt S, Beyer P, Butler M, Czaplewski L, Lienhardt C, Moja L, Paul M, Paulin S, Rex JH, Silver LL, Spigelman M, Thwaites GE, Paccaud JP, Harbarth S. The Lancet Infectious Diseases, October 2018, doi: 10.1016/S1473-3099(18)30513-9.